Fig. 6.
Monitoring of EBV-DNA load and CsA levels in patient 5.
A 13-year-old boy with AML received a TCD bone marrow graft from a mismatched unrelated donor. Grade 2 GVHD was treated with oral prednisolone and psoralen plus ultraviolet A. Four infusions of EBV-CTLs were given prophylactically starting from day +31. The last injection was postponed for 2 weeks because of fever, mild exacerbation of GVHD, and pancytopenia. The EBV-DNA load determined before BMT is shown by an isolated filled circle. *EBV-DNA was not detected in the DNA equivalent of 105cells.
